$2.02
0.021.00%
At Close: -
$1.99
-0.03-1.49%
After Hours: 6:54 PM EDT
15 minutes delayed
Cardiol Therapeutics
CRDLNASDAQ
Cardiol Therapeutics (CRDL) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCardiol Therapeutics (NASDAQ:CRDL) Stock Quotes, Forecast and News Summary
Cardiol Therapeutics Stock (NASDAQ: CRDL) stock price, news, charts, stock research, profile.
| Open | $2.01 |
| Close | $2.02 |
| Volume / Avg. | 357.45K / 499.83K |
| Day Range | 1.93 - 2.02 |
| 52 Wk Range | 0.66 - 3.12 |
| Market Cap | $137.31M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 42 |
| Short Interest | 1.18% |
| Days to Cover | 1 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About
Sector
Healthcare
Industry
N/A
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clini...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cardiol Therapeutics (CRDL) stock?
You can purchase shares of Cardiol Therapeutics (NASDAQ:CRDL) through any online brokerage.
Who are Cardiol Therapeutics (CRDL) competitors?
There are no as such competitors for Cardiol Therapeutics.
What is the target price for Cardiol Therapeutics (CRDL) stock?
There is no analysis for Cardiol Therapeutics.
What is the forecast for Cardiol Therapeutics (CRDL) stock?
Cardiol Therapeutics has a consensus price target of $7.50.
Current stock price for Cardiol Therapeutics (CRDL)?
The stock price for Cardiol Therapeutics (NASDAQ: CRDL) is $1.99 last updated June 28, 2024 at 6:54 PM EDT.
Does Cardiol Therapeutics (CRDL) pay a dividend?
There are no upcoming dividends for Cardiol Therapeutics.
When is Cardiol Therapeutics (NASDAQ:CRDL) reporting earnings?
Cardiol Therapeutics’s Q2 earnings are confirmed for Thursday, August 8, 2024.
Is Cardiol Therapeutics (CRDL) going to split?
There is no upcoming split for Cardiol Therapeutics.
What sector and industry does Cardiol Therapeutics (CRDL) operate in?
Cardiol Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.